拓維信息(002261.SZ):2022年公司的兆瀚昇騰AI產品連續中標重慶及長沙人工智能計算中心、全國一體化算力網絡國家(貴州)主樞紐中心項目
格隆匯6月2日丨拓維信息(002261.SZ)於2023年6月1日下午15:00-17:00召開業績説明會,交流環節中,就“目前公司有GPU業務嗎?未來有發展GPU的相關計劃或規劃嗎?”,公司回覆稱,2022年,公司的兆瀚昇騰AI產品連續中標重慶及長沙人工智能計算中心、全國一體化算力網絡國家(貴州)主樞紐中心項目;截止回覆之日,上述項目均已投入使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.